Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 8.12637 | 94 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.98915 | 93 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 8.28082 | 94 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.0849 | 93 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.14169 | 94 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.06198 | 95 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.5222 | 92 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.86237 | 93 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 8.02593 | 94 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 8.1263 | 94 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.9249 | 93 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 8.07681 | 94 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.15757 | 94 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 8.06608 | 94 |